ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer

Seasoned life sciences executive brings extensive business development expertiseLAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT) announced today it has appointed industry veteran David Gilman to the new role of Chief Business & Strategy Officer reporting to Chief Executive Officer Ameet Malli...

Related Keywords

New Jersey ,United States ,Switzerland ,London ,City Of ,United Kingdom ,Lausanne Biop ,Mary Ann Ondish ,David Gilman ,Eugenia Litz ,Amanda Hamilton ,Frankel Group Huron Consulting ,Linkedin ,Company On Twitter ,Business Development For Novartis Oncology ,University Of Texas ,University Of Chicago ,Novartis ,Chief Business ,Strategy Officer ,Chief Executive Officer Ameet Mallik ,Ameet Mallik ,Chief Executive Officer ,Global Head ,Portfolio Strategy ,Business Development ,Novartis Oncology ,Clearview Healthcare Partners ,Huron Consulting Group ,San Francisco Bay Area ,